Remove 2003 Remove Chemotherapy Remove Compounding Pharmacies
article thumbnail

Pharmacies Need Strategies to Improve Health Care Access

Pharmacy Times

Implementation and evaluation of social determinants of health practice models within community pharmacy. J Am Pharm Assoc (2003). Am J Health Syst Pharm. 2019;76(4):251-253. doi:10.1093/ajhp/zxy040 13. Foster AA, Daly CJ, Logan T, et al. 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In However, 505(b)(2) drugs have been available since the 1980s. “CMS

FDA 65
article thumbnail

STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties

STAT

Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions. Nearly 96% of pharmacy technicians report their pharmacy faces drug shortages , according to an online survey last month by the Pharmacy Technician Certification Board. Continue to STAT+ to read the full story…